C/O Acrivon Therapeutics, Inc., 480 Arsenal Way, Suite 100, Watertown, Massachusetts
Summary
The estimated net worth of Rasmus Holm-Jorgensen is at least $228 K dollars as of May 16, 2024. Rasmus Holm-Jorgensen is the Chief Financial Officer of Acrivon Therapeutics, Inc. and owns shares of Acrivon Therapeutics, Inc. (ACRV) stock worth about $228 K.
Insider Transactions Reported by Rasmus Holm-Jorgensen:
Sym
Company
Class
Transaction
%
Value $
Price $
Shares
Shares After
Date
Ownership
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.